Skip to content

Ethyl Chloride for NPWT

Evaluating the Efficacy of Ethyl Chloride on Patients' Reported Pain With Negative Pressure Wound Therapy

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04635696
Enrollment
100
Registered
2020-11-19
Start date
2019-01-07
Completion date
2020-12-10
Last updated
2021-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Acute

Brief summary

Negative pressure wound therapy (NPWT) has been shown to improve wound care outcomes for acute and chronic wounds as well as for surgical incision sites. We have found that patients report significant pain during dressing changes specifically with the removal of the clear adhesive drape. Upon review of the literature, there were multiple studies related to pain and the removal of the sponge (filler) but limited studies relating to the pain associated with the removal of the drape. The patient reported pain with drape removal has led to increased psychological stress and decreased compliance with the dressing change protocol. Application of a topical anesthetic to the drape during the dressing change has the potential to decrease the pain experienced by the patient. An FDA approved ethyl chloride spray is a topical anesthetic that can be sprayed onto the outer perimeter of the drape during the dressing change as a means to decrease pain. We hypothesize that the use of ethyl chloride spray will result in patients experiencing less pain leading to decreased psychological stress, improved compliance with dressing changes, and overall improved customer satisfaction.

Interventions

Pressurized vapocoolant developed for acute, mild pain relief.

OTHERTissue culture grade water

Pressurized water mist

Sponsors

ProMedica Health System
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* an orthopaedic/trauma wound and/or surgical incision * treatment with NPWT as a hospital inpatient * minimum of at least one NPWT dressing changes or discontinuation of NPWT prior to discharge. * dressing change in enterostomal therapy department

Exclusion criteria

* cognitive impairment preventing informed consent * history of hypersensitivity to cold/vapocoolant * outpatient NPWT

Design outcomes

Primary

MeasureTime frameDescription
Patient-reported post procedure painimmediately after drape removalPain reported on 0-10 numeric pain scale (NPS), where lower reported scores are favorable.
Patient-reported during procedure painduring drape removalPain reported on 1-10 numeric pain scale (NPS), where lower reported scores are favorable.

Secondary

MeasureTime frameDescription
Change in pain score from pre-procedure to post-procedureimmediately prior to drape change to immediately following drape changechange in pain reported on 0-10 numeric pain scale (NPS), where lower reported scores are favorable.
Change in pain score from pre-procedure to during procedureimmediately prior to drape change to during drape changechange in pain reported on 0-10 numeric pain scale (NPS), where lower reported scores are favorable.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026